SI
NTUS

Sapience Investments’s Natus Medical Inc NTUS Stock Holding History

Sapience Investments’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-138,005
Closed -$3.19M – 100
2020
Q1 		$3.19M Sell
138,005
-39,175
-22% -$1.14M 0.71% 64
2019
Q4 		$5.84M Sell
177,180
-12,340
-7% -$395K 0.82% 52
2019
Q3 		$6.03M Sell
189,520
-110,450
-37% -$3.22M 0.84% 52
2019
Q2 		$7.71M Sell
299,970
-2,150
-0.7% -$54.8K 1.05% 39
2019
Q1 		$7.67M Buy
302,120
+34,060
+13% +$1.02M 1.02% 42
2018
Q4 		$9.12M Sell
268,060
-62,770
-19% -$2.04M 1.49% 27
2018
Q3 		$11.8M Sell
330,830
-3,800
-1% -$134K 1.44% 28
2018
Q2 		$11.5M Sell
334,630
-4,650
-1% -$163K 1.53% 25
2018
Q1 		$11.4M Buy
+339,280
New +$10.7M 1.57% 24

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sapience Investments's NTUS Position: Q2 2020 in Review

Sapience Investments sold out of Natus Medical Inc (NTUS) in Q2 2020, closing a stake of 138,005 shares — an estimated $3.19M sold.

Sapience Investments first reported a position in NTUS in Q1 2018 and held it in 9 quarters. The position peaked at $11.8M in Q3 2018. 172 funds tracked by Wall St. Rank hold NTUS as of Q2 2020.

  • Sapience Investments reported no remaining Natus Medical Inc position as of Q2 2020 after selling out during the quarter.
  • Sapience Investments sold 138,005 Natus Medical Inc shares in Q2 2020, an estimated $3.19M.
  • Sapience Investments first reported a position in Natus Medical Inc in Q1 2018 and held it in 9 quarters.
  • Sapience Investments's Natus Medical Inc position peaked at $11.8M in Q3 2018.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2020.

Based on Sapience Investments's 13F filing for Q2 2020, filed 14 Aug 2020.